September 2026
The global orphan drugs market size was surpass to USD 242.97 billion in 2026 and is projected to reach around USD 676.59 billion by 2035 with a CAGR of 12.07%.
September 2026
The oncology/cancer drugs market size is calculated at USD 214.70 billion in 2026 and is projected to hit around USD 554.69 billion by 2035 with a CAGR of 11.17%.
September 2026
The atopic dermatitis drugs market size is calculated at USD 17.21 billion in 2026 and is projected to hit around USD 33.42 billion by 2035 with a CAGR of 7.70%.
September 2026
The global hyperlipidemia drugs market size is calculated at USD 24.80 billion in 2026 and is projected to surpass USD 35.24 billion by 2035 with a CAGR of 3.98%.
September 2026
The global pediatric drugs market size was estimated at USD 183.20 billion in 2026 and is projected to hit around USD 506.52 billion by 2035 with a CAGR of 11.99%.
September 2026
The anesthesia drugs market generated USD 7.92 billion in 2026, with prominent anesthesia drugs market companies including Envigo, JANVIER LABS, Taconic Biosciences Inc.
September 2026
The global fibrate drugs market size was valued at USD 3.70 billion in 2026 and is projected to attain around USD 5.67 billion by 2034 with a CAGR of 5.19%.
September 2026
The orphan disease biomarkers market expands with advancements in genomics, proteomics, and bioinformatics for rare conditions.
September 2026
The global anti-obesity drugs market size is estimated at USD 8.96 billion in 2026, and is projected to hit around USD 64.96 billion by 2035, with a CAGR of 24.71%.
September 2026
The omega 3 prescription drugs market size was valued at USD 1.66 billion in 2026 and is projected to hit around USD 2.93 billion by 2034 with a CAGR of 7.36%.
September 2026
The global inhalable drugs market size was valued at USD 35.44 billion in 2024 and is projected to cross around USD 65.51 billion by 2034 with a CAGR of 5.57%.
September 2026
The genitourinary drugs market size was USD 30.37 billion in 2026, with leading genitourinary drugs market players including Pfizer inc, johnson & johnson, bayer ag, Sanofi.
September 2026
The global atherosclerosis drugs market size is projected to hit around USD 25.07 billion by 2035, increasing from USD 18.24 billion in 2026, with a CAGR of 3.60%.
September 2026
The oral transmucosal drugs market size was valued at USD 41.82 billion in 2026 and is projected to attain around USD 70.37 billion by 2034 with a CAGR of 6.72%.
September 2026
The global 3D printed drugs market size was estimated at USD 400.73 million in 2026 and is predicted to reach around USD 789.20 million by 2034 with a CAGR of 8.84%.
September 2026
The global UTI drugs market size was evaluated at USD 5.34 billion in 2026 and is predicted to hit around USD 8.65 billion by 2035, growing at a CAGR of 5.50%.
September 2026
The global smart drugs market size was evaluated at USD 2.54 billion in 2026 and is predicted to hit around USD 6.24 billion by 2035, growing at a CAGR of 10.50%.
September 2026
The global allergy rhinitis drugs market size is expected to increase from USD 15.17 billion in 2026 to hit around USD 21.61 billion by 2035, growing at a CAGR of 4.01%.
September 2026
The asthma drugs market was valued at USD 27.87 billion in 2026 and is expected to hit around USD 42.74 billion by 2035, growing at a CAGR of 4.46% from 2026 to 2035.
September 2026
The global generic drugs market size is estimated at USD 491.67 billion in 2026 and is projected to reach USD 762.48 billion by 2035 at a 5% CAGR, driven by rising demand for affordable medicines and patent-expired drugs.
September 2026
The global HIV drugs market size is estimated at USD 40.86 billion in 2026 and is projected to hit around USD 69.88 billion by 2035, growing at a CAGR of 6.15%.
September 2026
The global atrial fibrillation drugs market size was evaluated at USD 16.54 billion in 2026 and is projected to surpass around USD 20.99 billion by 2034, with a CAGR of 3.02%.
September 2026
The global antidepressant drugs market size was evaluated at USD 20.09 billion in 2026 and is projected to cross around USD 26.06 billion by 2034, with a CAGR of 3.22%.
September 2026
The global companion animal drugs market size was evaluated at USD 17.01 billion in 2026 and is projected to reach around USD 29.42 billion by 2035, at a CAGR of 6.43%.
September 2026
The global lipase inhibitors obesity drugs market size was estimated at USD 1.65 billion in 2026 and is expected to hit around USD 4.94 billion by 2034, growing at a CAGR of 14.72%.
September 2026
The ovarian cancer drugs market reached USD 4.36 billion in 2026, with prominent companies such as AstraZeneca plc (UK), F. Hoffmann-La Roche Ltd. (Switzerland), GlaxoSmithKline plc (GSK) (UK), AbbVie Inc. (USA), Merck & Co., Inc. (USA) leading the ovarian cancer drugs market.
September 2026
The amylin analog drugs market size stood at USD 3.47 billion in 2026, with major Eli Lilly and Company, Sanofi S.A., Boehringer Ingelheim, Novartis AG. companies including amylin analog drugs market.
September 2026
The global injectable peptides drugs market size was evaluated at USD 53.07 billion in 2026 and is predicted to hit around USD 117.18 billion by 2035, growing at a CAGR of 9.20%.
September 2026
The U.S. cardiovascular drugs market was valued at USD 29.25 billion in 2026, with leading companies including Bristol-Myers Squibb, Bayer AG, Pfizer Inc.
September 2026
The AI in cancer immunotherapy drugs market reached USD 3.52 billion in 2026, featuring leading AI in cancer immunotherapy drugs market companies such as Exscientia, Insilico Medicine.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com